CMVpp65 epitope specificity of cord blood virus-specific T-cell lines
| Cord ID . | HLA typing cord . | CMVpp65 epitope(s) . | Predicted immunodominant CMVpp65 epitope(s) not identified . |
|---|---|---|---|
| CB1 | A2;3/B44;51 | 31-51: DTPVLPHETRLLQTGIHVRV126-146: INVHHYPSAAERKHRHLPVA | 495-503: NLVPMVATV |
| CB2 | A2;24/B7 | 120-129: MLNIPSINV351-371: LLQRGPQYSEHPTFT | 495-503: NLVPMVATV341-349: QYDPVAALF417-426: TPRVTGGGAM 265-275: RPHERNGFTVL |
| CB3 | A2;29/B35;44 | 31-51: DTPVLPHETRLLQTGIHVRV120-129: MLNIPSINV347-358: ALFFFDIDLLL | 495-503: NLVPMVATV |
| CB4 | A3/B7;44 | Pools 14,16,19 (epitope not identified) | 417-426: TPRVTGGGAM 265-275: RPHERNGFTVL |
| CB5 | A3;29/B44;45 | Pools 6,7,10,14,18 (epitope not identified) | N/A |
| CB6 | A2;33/B40(60);44 | 221-241: DQYVKVYLESFCEDVPSGKL256-276: MTRNPQPFMRPHERNGFTVL | 495-503: NLVPMVATV |
| CB7 | A11;30/B18;52 | 11-31:MISVLGPISGHVLKAVFSRG151-171:ASGKQMWQARLTVSGLAWTR | N/A |
| CB8 | A2;3/B8;18 | Not identified | 495-503: NLVPMVATV |
| CB9 | A29;31/B7;51 | 116-131: LPLKMLNIPSINVHHYPSAA | 417-426: TPRVTGGGAM265-275: RPHERNGFTVL |
| Cord ID . | HLA typing cord . | CMVpp65 epitope(s) . | Predicted immunodominant CMVpp65 epitope(s) not identified . |
|---|---|---|---|
| CB1 | A2;3/B44;51 | 31-51: DTPVLPHETRLLQTGIHVRV126-146: INVHHYPSAAERKHRHLPVA | 495-503: NLVPMVATV |
| CB2 | A2;24/B7 | 120-129: MLNIPSINV351-371: LLQRGPQYSEHPTFT | 495-503: NLVPMVATV341-349: QYDPVAALF417-426: TPRVTGGGAM 265-275: RPHERNGFTVL |
| CB3 | A2;29/B35;44 | 31-51: DTPVLPHETRLLQTGIHVRV120-129: MLNIPSINV347-358: ALFFFDIDLLL | 495-503: NLVPMVATV |
| CB4 | A3/B7;44 | Pools 14,16,19 (epitope not identified) | 417-426: TPRVTGGGAM 265-275: RPHERNGFTVL |
| CB5 | A3;29/B44;45 | Pools 6,7,10,14,18 (epitope not identified) | N/A |
| CB6 | A2;33/B40(60);44 | 221-241: DQYVKVYLESFCEDVPSGKL256-276: MTRNPQPFMRPHERNGFTVL | 495-503: NLVPMVATV |
| CB7 | A11;30/B18;52 | 11-31:MISVLGPISGHVLKAVFSRG151-171:ASGKQMWQARLTVSGLAWTR | N/A |
| CB8 | A2;3/B8;18 | Not identified | 495-503: NLVPMVATV |
| CB9 | A29;31/B7;51 | 116-131: LPLKMLNIPSINVHHYPSAA | 417-426: TPRVTGGGAM265-275: RPHERNGFTVL |
N/A indicates not applicable.